美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA205692"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0002-8214-05 0002-8214 HUMAN PRESCRIPTION DRUG BASAGLAR Tempo Pen Insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20191115 N/A BLA BLA205692 Eli Lilly and Company INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 CARTON (0002-8214-05) / 3 mL in 1 SYRINGE (0002-8214-01)
0002-7715-59 0002-7715 HUMAN PRESCRIPTION DRUG BASAGLAR KwikPen Insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20160617 N/A BLA BLA205692 Eli Lilly and Company INSULIN GLARGINE 100 [iU]/mL 5 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01)
0002-7715-63 0002-7715 HUMAN PRESCRIPTION DRUG BASAGLAR KwikPen Insulin glargine INJECTION, SOLUTION SUBCUTANEOUS 20160715 N/A BLA BLA205692 Eli Lilly and Company INSULIN GLARGINE 100 [iU]/mL 1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase